AR and prostate cancer: Therefore, it is compelling to speculate that transcriptional upregulation of PFKFB2 by androgen receptor signaling in hypoxia may represent a potential mechanism by which prostate cancer cells could allosterically upregulate glycolysis in the absence of HIF-1.